solifenacin succinate has been researched along with Intraocular Pressure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Coban, S; Demirci, H; Guzelsoy, M; Parmak Yener, N; Turkoglu, AR | 1 |
| Arslan, U; Dolen, I; Hekimoglu, E; Petricli, IS; Sekeroglu, MA; Tasci, Y | 1 |
| Coban, S; Demirbas, M; Demirci, H; Guzelsoy, M; Turkoglu, AR; Yener, NP | 1 |
3 other study(ies) available for solifenacin succinate and Intraocular Pressure
| Article | Year |
|---|---|
Comparison of the effects of trospium and solifenacin on intraocular pressure and tear secretion in patients with overactive bladder.
Topics: Adult; Aged; Humans; Intraocular Pressure; Middle Aged; Muscarinic Antagonists; Prospective Studies; Solifenacin Succinate; Treatment Outcome; Urinary Bladder, Overactive | 2021 |
The effect of oral solifenacin succinate treatment on intraocular pressure: glaucoma paradox during overactive bladder treatment.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive | 2014 |
Changes in intraocular pressure and tear secretion in patients given 5 mg solifenacin for the treatment of overactive bladder.
Topics: Administration, Oral; Adult; Aged; Dry Eye Syndromes; Female; Humans; Intraocular Pressure; Middle Aged; Muscarinic Antagonists; Nasolacrimal Duct; Prospective Studies; Solifenacin Succinate; Tears; Urinary Bladder, Overactive | 2017 |